Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical companies, including the makers of Xarelto, have a duty to make sure that their drugs are reasonably secure for use – and failure to do so could be grounds for compensation. Our lawyers are operating hard to obtain those hurt by the drug the compensation they’re entitled to.
Whilst bleeding is really a common complication connected with anticoagulants, it has been alleged that Xarelto is much more hazardous than traditional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This implies that, inside the occasion of an emergency, sufferers might be at risk for irreversible bleeding problems, which includes life-threatening internal and gastrointestinal hemorrhaging.
If you or possibly a loved one suffered a significant bleeding event following taking Xarelto, you may have legal recourse. For more data, contact us today to possess your case reviewed, free of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, pain and suffering and, in situations of death, funeral costs. Furthermore, they may be looking for punitive damages, which are normally awarded to punish the defendant and deter other companies from acting similarly.
Why Are Lawsuits Getting Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs within the lawsuits allege critical and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a xarelto ad user in the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.
Visit this page for far more data on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.